N/A
N=15
Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks
Stretch Marks · Striae Distensae · Cosmetic Appearance of Stretch Marks
Bottom Line
View on ClinicalTrials.gov: NCT02601105 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
May 2021
Primary outcome: Primary: Cosmetic Outcome- Fraction Improving by at Least 1 Point Increase in Overall Appearance of Stretch Marks — 3; 5 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Placebo Vehicle Cream (Other); Centella Asiatica Cream (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of California, Davis
- Primary completion
- Aug 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cosmetic Outcome- Fraction Improving by at Least 1 Point Increase in Overall Appearance of Stretch Marks |
3; 5 | — |
| PRIMARY Stretch Mark Width/Area |
0.8; 0.87 | — |
Summary
The purpose of this study is to clinically evaluate the efficacy, safety as well as patient satisfaction in the use of topical Centella asiatica (CA) on the cosmetic appearance of stretch marks.
Eligibility Criteria
Inclusion Criteria
- English-speaking subjects over the age of 18
- Subjects clinically diagnosed with stretch marks
Exclusion Criteria
- History of keloid scarring
- Isotretinoin use within the last 6 months
- Oral prednisone use within the last 3 months
- Non-ablative laser procedures to the abdomen within 1 year of study initiation
- Ablative resurfacing procedures to the abdomen within 3 years of the study initiation
- Pregnancy
- Use of immunosuppressive drugs
- Known hypersensitivity to Centella asiatica
Data sourced from ClinicalTrials.gov (NCT02601105). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.